Global Lercanidipine Hydrochloride Tablets Market Growth 2022-2028
The global market for Lercanidipine Hydrochloride Tablets is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Lercanidipine Hydrochloride Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Lercanidipine Hydrochloride Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Lercanidipine Hydrochloride Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Lercanidipine Hydrochloride Tablets market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Lercanidipine Hydrochloride Tablets players cover Abbott, Chongqing Shenghuaxi, Salubris Pharmaceuticals, Anhui Hongye Pharmaceutical and RECORDATI and etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Lercanidipine Hydrochloride Tablets market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Lercanidipine Hydrochloride Tablets market, with both quantitative and qualitative data, to help readers understand how the Lercanidipine Hydrochloride Tablets market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Lercanidipine Hydrochloride Tablets market and forecasts the market size by Type (10 mg and 20 mg,), by Application (Hypertension and Other.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
10 mg
20 mg
Segmentation by application
Hypertension
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Abbott
Chongqing Shenghuaxi
Salubris Pharmaceuticals
Anhui Hongye Pharmaceutical
RECORDATI
Accord Healthcare
Chapter Introduction
Chapter 1: Scope of Lercanidipine Hydrochloride Tablets, Research Methodology, etc.
Chapter 2: Executive Summary, global Lercanidipine Hydrochloride Tablets market size (sales and revenue) and CAGR, Lercanidipine Hydrochloride Tablets market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Lercanidipine Hydrochloride Tablets sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Lercanidipine Hydrochloride Tablets sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Lercanidipine Hydrochloride Tablets market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Abbott, Chongqing Shenghuaxi, Salubris Pharmaceuticals, Anhui Hongye Pharmaceutical, RECORDATI and Accord Healthcare, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Lercanidipine Hydrochloride Tablets Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Lercanidipine Hydrochloride Tablets by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Lercanidipine Hydrochloride Tablets by Country/Region, 2017, 2022 & 2028
2.2 Lercanidipine Hydrochloride Tablets Segment by Type
2.2.1 10 mg
2.2.2 20 mg
2.3 Lercanidipine Hydrochloride Tablets Sales by Type
2.3.1 Global Lercanidipine Hydrochloride Tablets Sales Market Share by Type (2017-2022)
2.3.2 Global Lercanidipine Hydrochloride Tablets Revenue and Market Share by Type (2017-2022)
2.3.3 Global Lercanidipine Hydrochloride Tablets Sale Price by Type (2017-2022)
2.4 Lercanidipine Hydrochloride Tablets Segment by Application
2.4.1 Hypertension
2.4.2 Other
2.5 Lercanidipine Hydrochloride Tablets Sales by Application
2.5.1 Global Lercanidipine Hydrochloride Tablets Sale Market Share by Application (2017-2022)
2.5.2 Global Lercanidipine Hydrochloride Tablets Revenue and Market Share by Application (2017-2022)
2.5.3 Global Lercanidipine Hydrochloride Tablets Sale Price by Application (2017-2022)
3 Global Lercanidipine Hydrochloride Tablets by Company
3.1 Global Lercanidipine Hydrochloride Tablets Breakdown Data by Company
3.1.1 Global Lercanidipine Hydrochloride Tablets Annual Sales by Company (2020-2022)
3.1.2 Global Lercanidipine Hydrochloride Tablets Sales Market Share by Company (2020-2022)
3.2 Global Lercanidipine Hydrochloride Tablets Annual Revenue by Company (2020-2022)
3.2.1 Global Lercanidipine Hydrochloride Tablets Revenue by Company (2020-2022)
3.2.2 Global Lercanidipine Hydrochloride Tablets Revenue Market Share by Company (2020-2022)
3.3 Global Lercanidipine Hydrochloride Tablets Sale Price by Company
3.4 Key Manufacturers Lercanidipine Hydrochloride Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Lercanidipine Hydrochloride Tablets Product Location Distribution
3.4.2 Players Lercanidipine Hydrochloride Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Lercanidipine Hydrochloride Tablets by Geographic Region
4.1 World Historic Lercanidipine Hydrochloride Tablets Market Size by Geographic Region (2017-2022)
4.1.1 Global Lercanidipine Hydrochloride Tablets Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Lercanidipine Hydrochloride Tablets Annual Revenue by Geographic Region
4.2 World Historic Lercanidipine Hydrochloride Tablets Market Size by Country/Region (2017-2022)
4.2.1 Global Lercanidipine Hydrochloride Tablets Annual Sales by Country/Region (2017-2022)
4.2.2 Global Lercanidipine Hydrochloride Tablets Annual Revenue by Country/Region
4.3 Americas Lercanidipine Hydrochloride Tablets Sales Growth
4.4 APAC Lercanidipine Hydrochloride Tablets Sales Growth
4.5 Europe Lercanidipine Hydrochloride Tablets Sales Growth
4.6 Middle East & Africa Lercanidipine Hydrochloride Tablets Sales Growth
5 Americas
5.1 Americas Lercanidipine Hydrochloride Tablets Sales by Country
5.1.1 Americas Lercanidipine Hydrochloride Tablets Sales by Country (2017-2022)
5.1.2 Americas Lercanidipine Hydrochloride Tablets Revenue by Country (2017-2022)
5.2 Americas Lercanidipine Hydrochloride Tablets Sales by Type
5.3 Americas Lercanidipine Hydrochloride Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Lercanidipine Hydrochloride Tablets Sales by Region
6.1.1 APAC Lercanidipine Hydrochloride Tablets Sales by Region (2017-2022)
6.1.2 APAC Lercanidipine Hydrochloride Tablets Revenue by Region (2017-2022)
6.2 APAC Lercanidipine Hydrochloride Tablets Sales by Type
6.3 APAC Lercanidipine Hydrochloride Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Lercanidipine Hydrochloride Tablets by Country
7.1.1 Europe Lercanidipine Hydrochloride Tablets Sales by Country (2017-2022)
7.1.2 Europe Lercanidipine Hydrochloride Tablets Revenue by Country (2017-2022)
7.2 Europe Lercanidipine Hydrochloride Tablets Sales by Type
7.3 Europe Lercanidipine Hydrochloride Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Lercanidipine Hydrochloride Tablets by Country
8.1.1 Middle East & Africa Lercanidipine Hydrochloride Tablets Sales by Country (2017-2022)
8.1.2 Middle East & Africa Lercanidipine Hydrochloride Tablets Revenue by Country (2017-2022)
8.2 Middle East & Africa Lercanidipine Hydrochloride Tablets Sales by Type
8.3 Middle East & Africa Lercanidipine Hydrochloride Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lercanidipine Hydrochloride Tablets
10.3 Manufacturing Process Analysis of Lercanidipine Hydrochloride Tablets
10.4 Industry Chain Structure of Lercanidipine Hydrochloride Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Lercanidipine Hydrochloride Tablets Distributors
11.3 Lercanidipine Hydrochloride Tablets Customer
12 World Forecast Review for Lercanidipine Hydrochloride Tablets by Geographic Region
12.1 Global Lercanidipine Hydrochloride Tablets Market Size Forecast by Region
12.1.1 Global Lercanidipine Hydrochloride Tablets Forecast by Region (2023-2028)
12.1.2 Global Lercanidipine Hydrochloride Tablets Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Lercanidipine Hydrochloride Tablets Forecast by Type
12.7 Global Lercanidipine Hydrochloride Tablets Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Lercanidipine Hydrochloride Tablets Product Offered
13.1.3 Abbott Lercanidipine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Chongqing Shenghuaxi
13.2.1 Chongqing Shenghuaxi Company Information
13.2.2 Chongqing Shenghuaxi Lercanidipine Hydrochloride Tablets Product Offered
13.2.3 Chongqing Shenghuaxi Lercanidipine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Chongqing Shenghuaxi Main Business Overview
13.2.5 Chongqing Shenghuaxi Latest Developments
13.3 Salubris Pharmaceuticals
13.3.1 Salubris Pharmaceuticals Company Information
13.3.2 Salubris Pharmaceuticals Lercanidipine Hydrochloride Tablets Product Offered
13.3.3 Salubris Pharmaceuticals Lercanidipine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Salubris Pharmaceuticals Main Business Overview
13.3.5 Salubris Pharmaceuticals Latest Developments
13.4 Anhui Hongye Pharmaceutical
13.4.1 Anhui Hongye Pharmaceutical Company Information
13.4.2 Anhui Hongye Pharmaceutical Lercanidipine Hydrochloride Tablets Product Offered
13.4.3 Anhui Hongye Pharmaceutical Lercanidipine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Anhui Hongye Pharmaceutical Main Business Overview
13.4.5 Anhui Hongye Pharmaceutical Latest Developments
13.5 RECORDATI
13.5.1 RECORDATI Company Information
13.5.2 RECORDATI Lercanidipine Hydrochloride Tablets Product Offered
13.5.3 RECORDATI Lercanidipine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 RECORDATI Main Business Overview
13.5.5 RECORDATI Latest Developments
13.6 Accord Healthcare
13.6.1 Accord Healthcare Company Information
13.6.2 Accord Healthcare Lercanidipine Hydrochloride Tablets Product Offered
13.6.3 Accord Healthcare Lercanidipine Hydrochloride Tablets Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Accord Healthcare Main Business Overview
13.6.5 Accord Healthcare Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Lercanidipine Hydrochloride Tablets Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Lercanidipine Hydrochloride Tablets Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 10 mg
Table 4. Major Players of 20 mg
Table 5. Global Lercanidipine Hydrochloride Tablets Sales by Type (2017-2022) & (K Units)
Table 6. Global Lercanidipine Hydrochloride Tablets Sales Market Share by Type (2017-2022)
Table 7. Global Lercanidipine Hydrochloride Tablets Revenue by Type (2017-2022) & ($ million)
Table 8. Global Lercanidipine Hydrochloride Tablets Revenue Market Share by Type (2017-2022)
Table 9. Global Lercanidipine Hydrochloride Tablets Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Lercanidipine Hydrochloride Tablets Sales by Application (2017-2022) & (K Units)
Table 11. Global Lercanidipine Hydrochloride Tablets Sales Market Share by Application (2017-2022)
Table 12. Global Lercanidipine Hydrochloride Tablets Revenue by Application (2017-2022)
Table 13. Global Lercanidipine Hydrochloride Tablets Revenue Market Share by Application (2017-2022)
Table 14. Global Lercanidipine Hydrochloride Tablets Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Lercanidipine Hydrochloride Tablets Sales by Company (2020-2022) & (K Units)
Table 16. Global Lercanidipine Hydrochloride Tablets Sales Market Share by Company (2020-2022)
Table 17. Global Lercanidipine Hydrochloride Tablets Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Lercanidipine Hydrochloride Tablets Revenue Market Share by Company (2020-2022)
Table 19. Global Lercanidipine Hydrochloride Tablets Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Lercanidipine Hydrochloride Tablets Producing Area Distribution and Sales Area
Table 21. Players Lercanidipine Hydrochloride Tablets Products Offered
Table 22. Lercanidipine Hydrochloride Tablets Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Lercanidipine Hydrochloride Tablets Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Lercanidipine Hydrochloride Tablets Sales Market Share Geographic Region (2017-2022)
Table 27. Global Lercanidipine Hydrochloride Tablets Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Lercanidipine Hydrochloride Tablets Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Lercanidipine Hydrochloride Tablets Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Lercanidipine Hydrochloride Tablets Sales Market Share by Country/Region (2017-2022)
Table 31. Global Lercanidipine Hydrochloride Tablets Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Lercanidipine Hydrochloride Tablets Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Lercanidipine Hydrochloride Tablets Sales by Country (2017-2022) & (K Units)
Table 34. Americas Lercanidipine Hydrochloride Tablets Sales Market Share by Country (2017-2022)
Table 35. Americas Lercanidipine Hydrochloride Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Lercanidipine Hydrochloride Tablets Revenue Market Share by Country (2017-2022)
Table 37. Americas Lercanidipine Hydrochloride Tablets Sales by Type (2017-2022) & (K Units)
Table 38. Americas Lercanidipine Hydrochloride Tablets Sales Market Share by Type (2017-2022)
Table 39. Americas Lercanidipine Hydrochloride Tablets Sales by Application (2017-2022) & (K Units)
Table 40. Americas Lercanidipine Hydrochloride Tablets Sales Market Share by Application (2017-2022)
Table 41. APAC Lercanidipine Hydrochloride Tablets Sales by Region (2017-2022) & (K Units)
Table 42. APAC Lercanidipine Hydrochloride Tablets Sales Market Share by Region (2017-2022)
Table 43. APAC Lercanidipine Hydrochloride Tablets Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Lercanidipine Hydrochloride Tablets Revenue Market Share by Region (2017-2022)
Table 45. APAC Lercanidipine Hydrochloride Tablets Sales by Type (2017-2022) & (K Units)
Table 46. APAC Lercanidipine Hydrochloride Tablets Sales Market Share by Type (2017-2022)
Table 47. APAC Lercanidipine Hydrochloride Tablets Sales by Application (2017-2022) & (K Units)
Table 48. APAC Lercanidipine Hydrochloride Tablets Sales Market Share by Application (2017-2022)
Table 49. Europe Lercanidipine Hydrochloride Tablets Sales by Country (2017-2022) & (K Units)
Table 50. Europe Lercanidipine Hydrochloride Tablets Sales Market Share by Country (2017-2022)
Table 51. Europe Lercanidipine Hydrochloride Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Lercanidipine Hydrochloride Tablets Revenue Market Share by Country (2017-2022)
Table 53. Europe Lercanidipine Hydrochloride Tablets Sales by Type (2017-2022) & (K Units)
Table 54. Europe Lercanidipine Hydrochloride Tablets Sales Market Share by Type (2017-2022)
Table 55. Europe Lercanidipine Hydrochloride Tablets Sales by Application (2017-2022) & (K Units)
Table 56. Europe Lercanidipine Hydrochloride Tablets Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Lercanidipine Hydrochloride Tablets Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Lercanidipine Hydrochloride Tablets Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Lercanidipine Hydrochloride Tablets Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Lercanidipine Hydrochloride Tablets Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Lercanidipine Hydrochloride Tablets Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Lercanidipine Hydrochloride Tablets Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Lercanidipine Hydrochloride Tablets Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Lercanidipine Hydrochloride Tablets Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Lercanidipine Hydrochloride Tablets
Table 66. Key Market Challenges & Risks of Lercanidipine Hydrochloride Tablets
Table 67. Key Industry Trends of Lercanidipine Hydrochloride Tablets
Table 68. Lercanidipine Hydrochloride Tablets Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Lercanidipine Hydrochloride Tablets Distributors List
Table 71. Lercanidipine Hydrochloride Tablets Customer List
Table 72. Global Lercanidipine Hydrochloride Tablets Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Lercanidipine Hydrochloride Tablets Sales Market Forecast by Region
Table 74. Global Lercanidipine Hydrochloride Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Lercanidipine Hydrochloride Tablets Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Lercanidipine Hydrochloride Tablets Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Lercanidipine Hydrochloride Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Lercanidipine Hydrochloride Tablets Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Lercanidipine Hydrochloride Tablets Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Lercanidipine Hydrochloride Tablets Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Lercanidipine Hydrochloride Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Lercanidipine Hydrochloride Tablets Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Lercanidipine Hydrochloride Tablets Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Lercanidipine Hydrochloride Tablets Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Lercanidipine Hydrochloride Tablets Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Lercanidipine Hydrochloride Tablets Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Lercanidipine Hydrochloride Tablets Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Lercanidipine Hydrochloride Tablets Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Lercanidipine Hydrochloride Tablets Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Lercanidipine Hydrochloride Tablets Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Lercanidipine Hydrochloride Tablets Revenue Market Share Forecast by Application (2023-2028)
Table 92. Abbott Basic Information, Lercanidipine Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Lercanidipine Hydrochloride Tablets Product Offered
Table 94. Abbott Lercanidipine Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Abbott Main Business
Table 96. Abbott Latest Developments
Table 97. Chongqing Shenghuaxi Basic Information, Lercanidipine Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Chongqing Shenghuaxi Lercanidipine Hydrochloride Tablets Product Offered
Table 99. Chongqing Shenghuaxi Lercanidipine Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Chongqing Shenghuaxi Main Business
Table 101. Chongqing Shenghuaxi Latest Developments
Table 102. Salubris Pharmaceuticals Basic Information, Lercanidipine Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Salubris Pharmaceuticals Lercanidipine Hydrochloride Tablets Product Offered
Table 104. Salubris Pharmaceuticals Lercanidipine Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Salubris Pharmaceuticals Main Business
Table 106. Salubris Pharmaceuticals Latest Developments
Table 107. Anhui Hongye Pharmaceutical Basic Information, Lercanidipine Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Anhui Hongye Pharmaceutical Lercanidipine Hydrochloride Tablets Product Offered
Table 109. Anhui Hongye Pharmaceutical Lercanidipine Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Anhui Hongye Pharmaceutical Main Business
Table 111. Anhui Hongye Pharmaceutical Latest Developments
Table 112. RECORDATI Basic Information, Lercanidipine Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 113. RECORDATI Lercanidipine Hydrochloride Tablets Product Offered
Table 114. RECORDATI Lercanidipine Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. RECORDATI Main Business
Table 116. RECORDATI Latest Developments
Table 117. Accord Healthcare Basic Information, Lercanidipine Hydrochloride Tablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Accord Healthcare Lercanidipine Hydrochloride Tablets Product Offered
Table 119. Accord Healthcare Lercanidipine Hydrochloride Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Accord Healthcare Main Business
Table 121. Accord Healthcare Latest Developments
List of Figures
Figure 1. Picture of Lercanidipine Hydrochloride Tablets
Figure 2. Lercanidipine Hydrochloride Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lercanidipine Hydrochloride Tablets Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Lercanidipine Hydrochloride Tablets Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Lercanidipine Hydrochloride Tablets Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 10 mg
Figure 10. Product Picture of 20 mg
Figure 11. Global Lercanidipine Hydrochloride Tablets Sales Market Share by Type in 2021
Figure 12. Global Lercanidipine Hydrochloride Tablets Revenue Market Share by Type (2017-2022)
Figure 13. Lercanidipine Hydrochloride Tablets Consumed in Hypertension
Figure 14. Global Lercanidipine Hydrochloride Tablets Market: Hypertension (2017-2022) & (K Units)
Figure 15. Lercanidipine Hydrochloride Tablets Consumed in Other
Figure 16. Global Lercanidipine Hydrochloride Tablets Market: Other (2017-2022) & (K Units)
Figure 17. Global Lercanidipine Hydrochloride Tablets Sales Market Share by Application (2017-2022)
Figure 18. Global Lercanidipine Hydrochloride Tablets Revenue Market Share by Application in 2021
Figure 19. Lercanidipine Hydrochloride Tablets Revenue Market by Company in 2021 ($ Million)
Figure 20. Global Lercanidipine Hydrochloride Tablets Revenue Market Share by Company in 2021
Figure 21. Global Lercanidipine Hydrochloride Tablets Sales Market Share by Geographic Region (2017-2022)
Figure 22. Global Lercanidipine Hydrochloride Tablets Revenue Market Share by Geographic Region in 2021
Figure 23. Global Lercanidipine Hydrochloride Tablets Sales Market Share by Region (2017-2022)
Figure 24. Global Lercanidipine Hydrochloride Tablets Revenue Market Share by Country/Region in 2021
Figure 25. Americas Lercanidipine Hydrochloride Tablets Sales 2017-2022 (K Units)
Figure 26. Americas Lercanidipine Hydrochloride Tablets Revenue 2017-2022 ($ Millions)
Figure 27. APAC Lercanidipine Hydrochloride Tablets Sales 2017-2022 (K Units)
Figure 28. APAC Lercanidipine Hydrochloride Tablets Revenue 2017-2022 ($ Millions)
Figure 29. Europe Lercanidipine Hydrochloride Tablets Sales 2017-2022 (K Units)
Figure 30. Europe Lercanidipine Hydrochloride Tablets Revenue 2017-2022 ($ Millions)
Figure 31. Middle East & Africa Lercanidipine Hydrochloride Tablets Sales 2017-2022 (K Units)
Figure 32. Middle East & Africa Lercanidipine Hydrochloride Tablets Revenue 2017-2022 ($ Millions)
Figure 33. Americas Lercanidipine Hydrochloride Tablets Sales Market Share by Country in 2021
Figure 34. Americas Lercanidipine Hydrochloride Tablets Revenue Market Share by Country in 2021
Figure 35. United States Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 36. Canada Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 37. Mexico Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 38. Brazil Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 39. APAC Lercanidipine Hydrochloride Tablets Sales Market Share by Region in 2021
Figure 40. APAC Lercanidipine Hydrochloride Tablets Revenue Market Share by Regions in 2021
Figure 41. China Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 42. Japan Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 43. South Korea Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 44. Southeast Asia Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 45. India Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 46. Australia Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 47. Europe Lercanidipine Hydrochloride Tablets Sales Market Share by Country in 2021
Figure 48. Europe Lercanidipine Hydrochloride Tablets Revenue Market Share by Country in 2021
Figure 49. Germany Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 50. France Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 51. UK Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 52. Italy Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 53. Russia Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 54. Middle East & Africa Lercanidipine Hydrochloride Tablets Sales Market Share by Country in 2021
Figure 55. Middle East & Africa Lercanidipine Hydrochloride Tablets Revenue Market Share by Country in 2021
Figure 56. Egypt Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 57. South Africa Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 58. Israel Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 59. Turkey Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 60. GCC Country Lercanidipine Hydrochloride Tablets Revenue Growth 2017-2022 ($ Millions)
Figure 61. Manufacturing Cost Structure Analysis of Lercanidipine Hydrochloride Tablets in 2021
Figure 62. Manufacturing Process Analysis of Lercanidipine Hydrochloride Tablets
Figure 63. Industry Chain Structure of Lercanidipine Hydrochloride Tablets
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets